Publicacións (26) Publicacións de Lara García Varela

2024

  1. Biodistribution and pharmacokinetics of [89Zr]-anti-VEGF mAbs using PET in glioblastoma rat models

    International Journal of Pharmaceutics, Vol. 652

  2. Quantitative brain [18F]FDG PET beyond normal blood glucose levels

    NeuroImage, Vol. 300

2023

  1. A murine model of BSCL2-associated Celia's encephalopathy

    Neurobiology of Disease, Vol. 187

  2. Quantitative PET tracking of intra-articularly administered 89Zr-peptide-decorated nanoemulsions

    Journal of Controlled Release, Vol. 356, pp. 702-713

2022

  1. Dose-response assessment of cerebral P-glycoprotein inhibition in vivo with [18F]MC225 and PET

    Journal of Controlled Release, Vol. 347, pp. 500-507

  2. Impact of an Adenosine A2AReceptor Agonist and Antagonist on Binding of the Dopamine D2Receptor Ligand [11C]raclopride in the Rodent Striatum

    Molecular Pharmaceutics, Vol. 19, Núm. 8, pp. 2992-3001

2021

  1. A new approach to produce [18F]MC225 via one-step synthesis, a PET radiotracer for measuring P-gp function

    EJNMMI Radiopharmacy and Chemistry, Vol. 6, Núm. 1

  2. Dermoscopy of Circumscribed Acral Hypokeratosis

    DERMATOLOGY PRACTICAL & CONCEPTUAL

  3. Evaluation of P-glycoprotein function at the blood–brain barrier using [18F]MC225-PET

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 48, Núm. 12, pp. 4105-4106

  4. Head-to-head comparison of (R)-[11C]verapamil and [18F]MC225 in non-human primates, tracers for measuring P-glycoprotein function

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 48, Núm. 13, pp. 4307-4317

  5. In Vivo Induction of P-Glycoprotein Function can be Measured with [18F]MC225 and PET

    Molecular Pharmaceutics, Vol. 18, Núm. 8, pp. 3073-3085

  6. Pharmacokinetic Modeling of (R)-[11C]verapamil to Measure the P-Glycoprotein Function in Nonhuman Primates

    Molecular Pharmaceutics, Vol. 18, Núm. 1, pp. 416-428

2020

  1. -FMISO PET/MRI Imaging Shows Ischemic Tissue around Hematoma in Intracerebral Hemorrhage

    Molecular Pharmaceutics, Vol. 17, Núm. 12, pp. 4667-4675

  2. PET imaging of ABC transporters at the blood-brain barrier

    PET and SPECT of Neurobiological Systems (Springer International Publishing), pp. 809-850

  3. Pharmacokinetic Modeling of [18F]MC225 for Quantification of the P-Glycoprotein Function at the Blood-Brain Barrier in Non-Human Primates with PET

    Molecular Pharmaceutics, Vol. 17, Núm. 9, pp. 3477-3486

  4. Test-Retest Repeatability of [18F]MC225-PET in Rodents: A Tracer for Imaging of P-gp Function

    ACS Chemical Neuroscience, Vol. 11, Núm. 4, pp. 648-658

2019

  1. Vaginal residence and pharmacokinetic preclinical study of topical vaginal mucoadhesive W/S emulsions containing ciprofloxacin

    International Journal of Pharmaceutics, Vol. 554, pp. 276-283

2017

  1. Positron emission tomography for the development and characterization of corneal permanence of ophthalmic pharmaceutical formulations

    Investigative Ophthalmology and Visual Science, Vol. 58, Núm. 2, pp. 772-780

  2. Preclinical PET study of intravitreal injections

    Investigative Ophthalmology and Visual Science, Vol. 58, Núm. 7, pp. 2843-2851

2016

  1. Identifying user requirements of wearable healthcare technologies for Chinese ageing population

    IEEE SECOND INTERNATIONAL SMART CITIES CONFERENCE (ISC2 2016)